Adoption of stereotactic ablative radiotherapy (SABR) technology for extracranial oligometastatic cancer in the NHS

Impact claim (as reported by the claimant) from REF 2021 impact case studies. Evidence status: source reported.

Organisation

King's College London

Source reference

756eebe6-793e-4f0e-9b95-a49e9585d288

Jurisdiction

United Kingdom

Licence

CC BY 4.0. © the submitting university; via UKRI REF 2021. Changed: summary of the impact only, formatting removed.

Impact case study submitted by King's College London to REF 2021 · Unit of assessment: Engineering · Summary impact type: Health · Imported because it names a tracked health-data resource

Source: https://results2021.ref.ac.uk/impact/756eebe6-793e-4f0e-9b95-a49e9585d288. Captured 2026-10-23.

Limitations: The submitting university's own account of its impact, written for assessment. OpenHDI has not checked the claim or its corroborating sources. A cited paper is underpinning research the university names; the case study does not establish that any particular data use caused the impact.